This inventor holds 1 USPTO granted patent. Top assignees: Northeastern University, Shanghai Sixth People's Hospital. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Innovations by Jingyi Lu in Glucose Management
Introduction
Jingyi Lu is an accomplished inventor based in Shanghai, China. He has made significant contributions to the field of glucose management through his innovative patent. His work focuses on improving the interpretation of ambulatory glucose profiles and insulin adjustment methods.
Latest Patents
Jingyi Lu holds a patent for an "Ambulatory glucose profile (AGP) intelligent interpretation and insulin adjustment method based on expert system." This patent involves establishing a knowledge base within an inference mechanism. It includes constructing an interpretation and decision support expert system with a simplified architecture based on the knowledge base. The method also features a patient problem analysis tree that addresses hypoglycemia, blood glucose fluctuation, and hyperglycemia. Additionally, it expands each rule with expert AGP interpretation and empirical data. The patent outlines the construction of basal and mealtime insulin dosage adjustment rules based on an interval type-2 fuzzy expert system. Finally, it provides decision suggestions by adjusting nodes in the patient problem analysis tree.
Career Highlights
Jingyi Lu has worked at notable institutions such as Northeastern University and Shanghai Sixth People's Hospital. His experience in these organizations has contributed to his expertise in glucose management and patient care.
Collaborations
Jingyi has collaborated with professionals like Xia Yu and Hongru Li, enhancing the quality and impact of his work in the field.
Conclusion
Jingyi Lu's innovative approach to glucose management through his patented methods demonstrates his commitment to improving patient outcomes. His contributions are significant in the realm of diabetes care and management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile